Suven Life Sciences Limited
NSE: SUVEN BSE: SUVEN
NSE
148.16
10.24 (7.42%)
Prev Close
137.92
Open Price
145
Volume
349,103
Today Low / High
141.3 / 151.4
52 WK Low / High
102.5 / 299.99
Range
141 - 156
BSE
148.20
10.55 (7.66%)
Prev Close
137.65
Open Price
145
Volume
12,929
Today Low / High
141.5 / 151.3
52 WK Low / High
102.7 / 303
Range
141 - 156
The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 148.16 (target range: 141 - 156), reflecting a change of 10.24 (7.42459%). On the BSE, it is listed at 148.2 (target range: 141 - 156), showing a change of 10.55 (7.66437%). Both the NSE and BSE data indicate positive movement, suggesting the stock is on an upward trend. This could be an attractive opportunity for investors looking for growth.
03 Feb
145.00
2.28%
02 Feb
139.90
-1.42%
01 Feb
134.00
3.95%
30 Jan
131.00
1.38%
29 Jan
131.99
-0.56%
28 Jan
127.20
3.77%
27 Jan
133.25
-4.89%
23 Jan
137.87
-2.76%
22 Jan
135.98
1.39%
21 Jan
142.50
-5.22%
20 Jan
151.00
-4.97%
19 Jan
149.85
0.26%
16 Jan
155.25
-3.15%
14 Jan
156.00
-0.97%
13 Jan
155.00
-1.21%
12 Jan
160.95
-4.15%
09 Jan
165.40
-3.46%
08 Jan
173.88
-5.58%
07 Jan
169.99
2.02%
06 Jan
161.25
5.77%
Suven Life Sciences Limited Graph
Suven Life Sciences Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Suven Life Sciences Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 148.16, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 148.20 | 149.68 | 134.71 - 164.65 |
| 151.16 | 120.93 - 181.40 | ||
| 152.65 | 106.85 - 198.44 | ||
| Bearish Scenario | 148.20 | 146.72 | 132.05 - 161.39 |
| 145.24 | 116.19 - 174.28 | ||
| 143.75 | 100.63 - 186.88 |
Overview of Suven Life Sciences Limited
ISIN
INE495B01038
Industry
Drug Manufacturers - Specialty & Generic
Vol.Avg
236,787
Market Cap
33,677,525,700
Last Dividend
0
Official Website
IPO Date
2003-10-24
DCF Diff
143.86
DCF
-6
Financial Ratios Every Investor Needs
Stock Dividend of SUVEN
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2019-02-14 | February 14, 19 | 1.38194 | 1.5 | 2019-02-15 | 2019-02-25 | 2019-01-29 |
| 2018-02-06 | February 06, 18 | 1.38194 | 1.5 | 2018-02-07 | 2018-03-01 | 2018-01-19 |
| 2017-02-08 | February 08, 17 | 0.9213 | 1 | 2017-02-09 | 2017-03-03 | 2017-01-23 |
| 2016-03-14 | March 14, 16 | 0.9213 | 1 | 2016-03-15 | 2016-03-23 | 2016-03-05 |
| 2015-07-23 | July 23, 15 | 0.55278 | 0.6 | 2015-07-24 | 2015-09-13 | 2015-05-26 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 6.66 Cr | 34.29 Cr | -27.63 Cr | -4.1518 | 143.96 Cr | 2.64 Cr | -171.60 Cr | -160.75 Cr | -7.36 | -154.88 Cr | -24.1511 |
| 2024-03-31 | 11.69 Cr | 0.82 Cr | 10.87 Cr | 0.9295 | 114.43 Cr | 2.71 Cr | -122.58 Cr | -105.08 Cr | -4.82 | -99.28 Cr | -8.9863 |
| 2023-03-31 | 13.54 Cr | 0.57 Cr | 12.97 Cr | 0.9582 | 115.35 Cr | 2.53 Cr | -131.92 Cr | -118.27 Cr | -7.50 | -111.31 Cr | -8.7352 |
| 2022-03-31 | 11.84 Cr | 25.58 Cr | -13.73 Cr | -1.1593 | 106.37 Cr | 2.49 Cr | -126.22 Cr | -122.00 Cr | -7.73 | -116.93 Cr | -10.2999 |
| 2021-03-31 | 13.48 Cr | 0.10 Cr | 13.38 Cr | 0.9924 | 71.03 Cr | 2.29 Cr | -83.87 Cr | -72.15 Cr | -4.57 | -72.19 Cr | -5.3531 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 37.73 Cr | 135.18 Cr | 25.20 Cr | 109.9868 Cr | 0.00 Cr | -37.73 Cr | 0.24 Cr | 59.48 Cr | 0.00 Cr | 0.00 Cr | 0.05 Cr | 23.4860 Cr |
| 2024-03-31 | 14.93 Cr | 284.90 Cr | 14.86 Cr | 270.0406 Cr | 0.71 Cr | -14.22 Cr | 0.71 Cr | 28.01 Cr | 0.00 Cr | 0.00 Cr | 0.02 Cr | 13.5161 Cr |
| 2023-03-31 | 37.02 Cr | 388.91 Cr | 13.59 Cr | 375.3193 Cr | 1.61 Cr | -35.41 Cr | 0.01 Cr | 37.02 Cr | 0.00 Cr | 0.00 Cr | 100.00 Cr | 11.1296 Cr |
| 2022-03-31 | 5.27 Cr | 108.03 Cr | 11.89 Cr | 96.1454 Cr | 3.21 Cr | -2.07 Cr | 0.03 Cr | 40.89 Cr | 4.09 Cr | 0.00 Cr | 0.00 Cr | 8.3147 Cr |
| 2021-03-31 | 9.35 Cr | 128.42 Cr | 20.41 Cr | 108.0057 Cr | 4.76 Cr | -4.58 Cr | 0.64 Cr | 25.60 Cr | 10.16 Cr | 0.00 Cr | -0.09 Cr | 15.9095 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | -148.4687 Cr | 149.2715 Cr | -0.7097 Cr | -185.7445 Cr | 0.0460 Cr | 15.0255 Cr | -37.2758 Cr | -160.7450 Cr | -0.7097 Cr | 0.0000 Cr | 0.4710 Cr |
| 2024-03-31 | -115.4690 Cr | 94.4363 Cr | -1.0540 Cr | -115.4690 Cr | -22.0867 Cr | 14.9324 Cr | 0.0000 Cr | -105.0763 Cr | -0.8956 Cr | 0.0000 Cr | -0.7084 Cr |
| 2023-03-31 | -103.1482 Cr | -260.6454 Cr | 395.5391 Cr | -106.0430 Cr | 31.7455 Cr | 37.0191 Cr | -2.8948 Cr | -118.2678 Cr | -0.4843 Cr | 0.0000 Cr | 0.0224 Cr |
| 2022-03-31 | -127.5370 Cr | -22.2292 Cr | 145.6916 Cr | -147.3086 Cr | -4.0746 Cr | 5.2736 Cr | -19.7716 Cr | -121.9951 Cr | -0.8523 Cr | 0.0000 Cr | 0.1191 Cr |
| 2021-03-31 | -96.0236 Cr | 55.8404 Cr | 34.8556 Cr | -102.3283 Cr | -5.3275 Cr | 9.3482 Cr | -6.3047 Cr | -77.4741 Cr | -0.6924 Cr | 0.0000 Cr | -0.1415 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | 2.81 Cr | 13.46 Cr | -10.65 Cr | -3.7915 | -104.70 Cr | -101.92 Cr | -4.55 | -100.58 Cr | -36.2879 |
| 2025-09-30 | 0.92 Cr | 11.69 Cr | -10.77 Cr | -11.7130 | -81.09 Cr | -77.31 Cr | -3.48 | -75.99 Cr | -84.1056 |
| 2025-06-30 | 1.87 Cr | 12.50 Cr | 1.87 Cr | 1.0000 | -52.12 Cr | -51.52 Cr | -2.36 | -50.15 Cr | -27.5978 |
| 2025-03-31 | 1.47 Cr | 9.31 Cr | -7.84 Cr | -5.3459 | -45.17 Cr | -43.94 Cr | -2.01 | -42.60 Cr | -29.9556 |
| 2024-12-31 | 1.61 Cr | 8.22 Cr | 1.61 Cr | 1.0000 | -40.74 Cr | -39.12 Cr | -1.79 | -37.58 Cr | -24.2975 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 9.61 Cr | 248.90 Cr | 258.51 Cr | 1.07 Cr | 0.24 Cr | 278.17 Cr | 58.93 Cr | 337.41 Cr | 56.14 Cr |
| 2025-06-30 | 0.00 Cr | 0.00 Cr | 60.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -109.99 Cr |
| 2025-03-31 | 37.73 Cr | 22.28 Cr | 60.00 Cr | 1.41 Cr | 0.24 Cr | 75.47 Cr | 59.48 Cr | 135.18 Cr | 25.20 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 166.48 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -192.68 Cr |
| 2024-09-30 | 92.49 Cr | 73.99 Cr | 166.48 Cr | 1.48 Cr | 0.70 Cr | 186.56 Cr | 25.16 Cr | 211.96 Cr | 19.28 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | -51.52 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2025-03-31 | -43.94 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-12-31 | -39.12 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | -49.64 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | -28.04 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| 2022-10-17 | October 17, 22 | 217:200 |
| 2007-03-23 | March 23, 07 | 2:1 |
| 2004-01-15 | January 15, 04 | 5:1 |
Similar Stocks: Drug Manufacturers - Specialty & Generic
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | SUNPHARMA | ₹1,707.60 | ₹4,097,104,394,772.00 | ₹4,557,769.00 |
| Divi's Laboratories Limited | DIVISLAB | ₹6,272.00 | ₹1,665,018,933,760.00 | ₹289,506.00 |
| Torrent Pharmaceuticals Limited | TORNTPHARM | ₹4,036.90 | ₹1,366,270,396,736.00 | ₹286,467.00 |
| Dr. Reddy's Laboratories Limited | DRREDDY | ₹1,235.30 | ₹1,028,471,485,107.00 | ₹956,827.00 |
| Lupin Limited | LUPIN | ₹2,194.20 | ₹1,002,308,365,800.00 | ₹620,016.00 |
| Zydus Lifesciences Limited | ZYDUSLIFE | ₹901.15 | ₹906,767,760,089.00 | ₹423,303.00 |
| Mankind Pharma Limited | MANKIND | ₹2,168.40 | ₹895,126,518,125.00 | ₹336,863.00 |
| Aurobindo Pharma Limited | AUROPHARMA | ₹1,236.00 | ₹717,870,806,028.00 | ₹1,401,552.00 |
| Alkem Laboratories Limited | ALKEM | ₹5,738.00 | ₹686,063,970,000.00 | ₹96,194.00 |
| Glenmark Pharmaceuticals Limited | GLENMARK | ₹1,967.50 | ₹555,230,091,708.00 | ₹269,835.00 |
| Laurus Labs Limited | LAURUSLABS | ₹976.55 | ₹527,196,945,152.00 | ₹1,079,882.00 |
| Suven Pharmaceuticals Limited | SUVENPHAR | ₹1,078.00 | ₹412,407,234,624.00 | ₹1,177,218.00 |
| Ipca Laboratories Limited | IPCALAB | ₹1,444.30 | ₹366,425,002,057.00 | ₹73,481.00 |
| Ajanta Pharma Limited | AJANTPHARM | ₹2,879.30 | ₹359,727,142,183.00 | ₹63,910.00 |
| J. B. Chemicals & Pharmaceuticals Limited | JBCHEPHARM | ₹1,897.50 | ₹304,425,412,500.00 | ₹105,241.00 |
| Emcure Pharmaceuticals Ltd. | EMCURE | ₹1,507.50 | ₹285,780,604,050.00 | ₹78,472.00 |
| Piramal Enterprises Limited | PEL | ₹1,124.20 | ₹254,856,250,172.00 | ₹2,148,582.00 |
| Wockhardt Limited | WOCKPHARMA | ₹1,351.70 | ₹219,640,664,837.00 | ₹477,810.00 |
| AstraZeneca Pharma India Limited | ASTRAZEN | ₹8,715.50 | ₹217,887,500,000.00 | ₹3,219.00 |
| Eris Lifesciences Limited | ERIS | ₹1,431.00 | ₹194,926,371,021.00 | ₹16,896.00 |
| Neuland Laboratories Limited | NEULANDLAB | ₹13,419.00 | ₹172,164,280,491.00 | ₹20,874.00 |
| Alembic Pharmaceuticals Limited | APLLTD | ₹789.95 | ₹155,275,039,804.00 | ₹17,361.00 |
| Jubilant Pharmova Limited | JUBLPHARMA | ₹979.90 | ₹155,186,516,065.00 | ₹108,835.00 |
| NATCO Pharma Limited | NATCOPHARM | ₹854.05 | ₹152,968,784,474.00 | ₹417,943.00 |
| Cohance Lifesciences Limited | COHANCE | ₹384.70 | ₹147,173,578,758.00 | ₹163,245.00 |
| Caplin Point Laboratories Limited | CAPLIPOINT | ₹1,830.60 | ₹139,147,010,698.00 | ₹35,647.00 |
| Granules India Limited | GRANULES | ₹572.35 | ₹138,891,439,603.00 | ₹376,351.00 |
| Glenmark Life Sciences Limited | GLS | ₹1,086.00 | ₹133,070,838,000.00 | ₹130,938.00 |
| Alivus Life Sciences Ltd. | ALIVUS | ₹951.35 | ₹116,764,893,600.00 | ₹40,499.00 |
| Viyash Scientific Limited | VIYASH | ₹216.00 | ₹94,220,400,744.00 | ₹1,123,427.00 |
| Procter & Gamble Health Limited | PGHL | ₹5,295.00 | ₹87,893,727,690.00 | ₹13,037.00 |
| Strides Pharma Science Limited | STAR | ₹861.80 | ₹79,434,444,925.00 | ₹174,461.00 |
| Aarti Pharmalabs Limited | AARTIPHARM | ₹788.05 | ₹71,434,600,037.00 | ₹103,646.00 |
| Akums Drugs & Pharmaceuticals Ltd. | AKUMS | ₹452.55 | ₹69,286,336,348.00 | ₹90,762.00 |
| FDC Limited | FDC | ₹381.60 | ₹62,128,328,054.00 | ₹29,678.00 |
| Shilpa Medicare Limited | SHILPAMED | ₹300.65 | ₹58,801,672,980.00 | ₹284,714.00 |
| Sequent Scientific Limited | SEQUENT | ₹202.40 | ₹50,564,340,966.00 | ₹13,647.00 |
| Sun Pharma Advanced Research Company Limited | SPARC | ₹143.67 | ₹46,624,016,548.00 | ₹3,535,043.00 |
| Innova Captab Limited | INNOVACAP | ₹720.05 | ₹41,204,810,126.00 | ₹42,280.00 |
| Aarti Drugs Limited | AARTIDRUGS | ₹401.65 | ₹36,658,595,500.00 | ₹132,983.00 |
| Gujarat Themis Biosyn Ltd. | GUJTHEM | ₹327.10 | ₹35,642,538,182.00 | ₹23,293.00 |
| Orchid Pharma Limited | ORCHPHARMA | ₹684.35 | ₹34,709,619,507.00 | ₹34,343.00 |
| Suven Life Sciences Limited | SUVEN | ₹148.17 | ₹33,704,822,580.00 | ₹349,103.00 |
| RPG Life Sciences Limited | RPGLIFE | ₹1,986.10 | ₹32,848,137,692.00 | ₹7,446.00 |
| Gufic Biosciences Limited | GUFICBIO | ₹310.30 | ₹31,117,661,612.00 | ₹26,127.00 |
| Unichem Laboratories Limited | UNICHEMLAB | ₹398.55 | ₹28,060,211,663.00 | ₹31,382.00 |
Key Executives
President & Chief Scientific Officer
N. V. S. Ramakrishna
Gender: Not Specified
Year Born: 1962
Chief Financial Officer
Mohan Kumar
Gender: male
Year Born:
Company Secretary & Compliance Officer
Shrenik Soni
Gender: male
Year Born:
Chief Executive Officer, MD & Executive Chairman
Venkateswarlu Jasti
Gender: male
Year Born: 1949
President of US Operations
Kalyani Jasti
Gender: female
Year Born: 1979
Whole-Time Director
Sudharani Jasti
Gender: female
Year Born: 1954
FAQs about Suven Life Sciences Limited
Who is the CEO of the company?
The CEO is Venkateswarlu Jasti.
What is the current market price of the stock?
The current price is ₹148.05.
What is the 52-week price range?
The range is ₹102.5-299.99.
What is the market capitalization of the company?
The market capitalization is ₹3,367.75 crores.
What is the Price-to-Earnings (P/E) ratio?
The P/E ratio is -12.07.
Which sector does the company belong to?
The company operates in the Healthcare sector.
What does the company do?
Overview of Suven Life Sciences Limited (ISIN: INE495B01038) is a leading Drug Manufacturers - Specialty & Generic in India. With a market capitalization of ₹3,367.75 crores and an average daily volume of 236,787 shares, it operates in the Drug Manufacturers - Specialty & Generic. The company last declared a dividend of ₹0.